An Open Label Extension Study of UT-15C in subjects with Pulmonary Arterial Hypertension

Update Il y a 4 ans
Reference: EUCTR2012-000098-21

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study is to provide UT-15C sustained release tablets for eligible subjects who participated in TDE-PH-310 (A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects with Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy).


Inclusion criteria

  • pulmonary arterial hypertension